Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 841 across all filing types
Latest filing 2026-05-25 Share Issue/Capital Cha…
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - BXN 7 pages 21.0KB
Share Issue/Capital Change Classification · 85% confidence The document is an ASX Appendix 2A “Application for quotation of securities,” detailing the issue and quotation of new ordinary shares as existing options are exercised. It is not a financial report or general regulatory notice but a capital change announcement. This matches the Share Issue/Capital Change category (Code: SHA).
2026-05-25 English
Notice of General Meeting/Proxy Form 12 pages 327.8KB
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a Notice of General Meeting with an Explanatory Memorandum and Proxy Form, detailing resolutions to be voted on, voting procedures, and proxy instructions. It is sent to shareholders to inform them of the meeting and solicit their votes. This aligns with the definition of Proxy Solicitation & Information Statement (PSI), which covers materials provided to shareholders to request and guide voting at a meeting.
2026-05-20 English
Letter to Shareholders re General Meeting Notice 2 pages 374.2KB
Proxy Solicitation & Information Statement Classification · 88% confidence The document is a Notice of General Meeting and Proxy Form sent to shareholders ahead of the meeting, containing meeting details, resolutions and instructions on lodging proxies. This falls squarely under materials sent to shareholders to provide information and request votes (Proxy Solicitation & Information Statement), not an AGM presentation or vote results. Therefore, it should be classified as PSI.
2026-05-20 English
Consolidation/Split - BXN 5 pages 19.7KB
Share Issue/Capital Change Classification · 90% confidence The document is an ASX announcement titled “Notification of security consolidation or split,” detailing a corporate action to consolidate shares, including record dates, effective dates, ratio, and post-consolidation share counts. This falls under capital structure changes (stock split/consolidation), matching the “Share Issue/Capital Change” category.
2026-05-20 English
Application for quotation of securities - BXN 9 pages 26.7KB
Share Issue/Capital Change Classification · 85% confidence The document is an ASX Appendix 2A form titled “Application for quotation of securities,” detailing the conversion of options into ordinary fully paid shares and the issuance of new securities, including numbers, issue dates, and prices. This constitutes an announcement of new share issuance and changes in the company’s capital structure. Under our taxonomy, this corresponds to Share Issue/Capital Change (SHA).
2026-05-19 English
Change of Director's Interest Notice 2 pages 212.8KB
Director's Dealing Classification · 98% confidence The document is an ASX Appendix 3Y ‘Change of Director’s Interest Notice’ under listing rule 3.19A.2, detailing a director’s acquisition and disposal of shares/options. This is a report of personal share transactions by a director, matching the definition of 'Director’s Dealing'.
2026-05-14 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.